Zobrazeno 1 - 10
of 29
pro vyhledávání: '"ARBs, angiotensin receptor blockers"'
Publikováno v:
Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6465-6470 (2021)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
The use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in coronavirus disease 2019 (COVID-19) patients has been claimed as associated with the risk of COVID-19 infection and its subsequent morbidities and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d5f9b3141b315ed573222f71db5af3
http://www.sciencedirect.com/science/article/pii/S1319562X2100574X
http://www.sciencedirect.com/science/article/pii/S1319562X2100574X
Autor:
Kaixuan Yan, Yong Yang, Shuang Hua, Ying Xu, Xue Jiang, Jufei Li, Xianglu Rong, Danqi Zou, Dewei Ye
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 140, Iss, Pp 111685-(2021)
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Type 2 diabetes mellitus, obesity, hypertension, and other associated metabolic complications have been demonstrated as a crucial contributor to the enhanced morbidity and mortality of patients with coronavirus disease 2019 (COVID-19). Data on the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03997d986ad803566f507d23d3831d1d
http://www.sciencedirect.com/science/article/pii/S0753332221004674
http://www.sciencedirect.com/science/article/pii/S0753332221004674
Publikováno v:
Journal of Diabetes and Its Complications
Evidence suggests that diabetes is one the most relevant comorbidity in affecting the prognosis of COVID-19. Albeit there are no specific trials nor subgroup analysis showing the effect of COVID-19 therapies in patients with diabetes, selected featur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b659b0007b9c0ee77bf66d3d8c4d800
https://pubmed.ncbi.nlm.nih.gov/33896714
https://pubmed.ncbi.nlm.nih.gov/33896714
Autor:
Christopher Oddy, Polly Keeling, Dhanuja Senn, Neesha Soni, Hannah Morrison, Ruwani Mawella, Thomas Samuel, John Dixon, Jonathan Allington, James McCaul
Publikováno v:
Clinical Therapeutics
PURPOSE: Due to the affinity of severe acute respiratory syndrome coronavirus 2 for the human angiotensin-converting enzyme 2 (ACE2) receptor, use of ACE inhibitors and angiotensin receptor blockers (ARBs) has been a major concern for clinicians duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d38193b72716773084906cfe09a43dd
http://europepmc.org/articles/PMC7906507
http://europepmc.org/articles/PMC7906507
Autor:
Semir Vranic, Maha Al-Asmakh, Ishita Gupta, Ahmed H. Amarah, Muhammad Umar Sohail, Ala-Eddin Al Moustafa, Khaled E. Elzawawi
Publikováno v:
Computational and Structural Biotechnology Journal
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 1654-1660 (2021)
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 1654-1660 (2021)
Graphical abstract
Susceptibility to severe illness from COVID-19 is anticipated to be associated with cigarette smoking as it aggravates the risk of cardiovascular and respiratory illness, including infections. This is particularly important wi
Susceptibility to severe illness from COVID-19 is anticipated to be associated with cigarette smoking as it aggravates the risk of cardiovascular and respiratory illness, including infections. This is particularly important wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fce205d35bae79eb29d825fbfe8d236
https://pubmed.ncbi.nlm.nih.gov/33777332
https://pubmed.ncbi.nlm.nih.gov/33777332
Publikováno v:
Gastroenterology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07a0580b8b681f82e8b142ff343f27d
https://pubmed.ncbi.nlm.nih.gov/33058865
https://pubmed.ncbi.nlm.nih.gov/33058865
Publikováno v:
Biochemical Pharmacology
Graphical abstract
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3288262888c0c58d8afaae1b90afb12
http://europepmc.org/articles/PMC7250789
http://europepmc.org/articles/PMC7250789
Autor:
Coats, Andrew Js, Chioncel, Ovidiu, Spoletini, Ilaria, Rosano, Giuseppe, Serenelli, Matteo, Jackson, Alice, Dewan, Pooja, Jhund, Pardeep, Petrie, Mark, Rossignol, Patrick, Campo, Gianluca, Pitt, Bertram, Zannad, Faiez, Ferreira, Joao Pedro, McMurray, John J.V.
Publikováno v:
JACC: Heart Failure
JACC: Heart Failure, Elsevier/American College of Cardiology, 2020, 8 (3), pp.188-198. ⟨10.1016/j.jchf.2019.09.011⟩
Jacc. Heart Failure
JACC: Heart Failure, Elsevier/American College of Cardiology, 2020, 8 (3), pp.188-198. ⟨10.1016/j.jchf.2019.09.011⟩
Jacc. Heart Failure
Objectives The purpose of this study was to investigate the effects of mineralocorticoid receptor antagonists (MRAs) on systolic blood pressure (SBP) and outcomes according to baseline SBP in patients with heart failure with reduced ejection fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5993a2fad99efc20cdaec1689590b2
https://hal.univ-lorraine.fr/hal-02516098
https://hal.univ-lorraine.fr/hal-02516098
Publikováno v:
Oncotarget
// Yating Li 1 , Hong Xu 2 , Wenrui Wu 1 , Jianzhong Ye 1 , Daiqiong Fang 1 , Ding Shi 1 and Lanjuan Li 1 1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7e204d09b029fbadc410ec7daffccf8
http://europepmc.org/articles/PMC5963622
http://europepmc.org/articles/PMC5963622
Autor:
Luis Alcocer, Davide Croce, William J. Valentine, Daniela Deroche-Chibedi, Anton V. Rodionov, Denis Granados, Il Suk Sohn, Ji-Guang Wang, Martin Rosas, Claudio Borghi
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 10, Iss, Pp 200102-(2021)
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 10, Iss, Pp 200102-(2021)
Background It is well established that single pill combination (SPC) therapies have the potential to improve patient adherence versus multi-pill regimens, thereby improving blood pressure control and clinical outcomes in populations with hypertension
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad44ee59a4a3a1265c4d71d4f456737
https://doi.org/10.1016/j.ijcrp.2021.200102
https://doi.org/10.1016/j.ijcrp.2021.200102